Literature DB >> 26823855

Correlation between microRNA-421 expression level and prognosis of gastric cancer.

Haiyan Liu1, Yongjian Gao2, Defeng Song2, Tong Liu2, Ye Feng2.   

Abstract

The expression of microRNA-421 (miR-421) is significantly elevated in gastric carcinoma cells, thus may play an important role in tumor occurrence. This study thus aimed to further illustrate the correlation between miR-421 expression level and the progression and prognosis of gastric carcinoma. A total of 96 gastric carcinoma tissue samples were quantified for miR-421 expression level using quantitative PCR (qPCR) method. Kaplan-Meier survival curve was further deployed to analyze the postoperative survival of all patients. No significant correlation existed between miR-421 level and general information of patients such as age, sex, tumor size, location, invasion depth, TNM stage, differentiation stage and metastasis. However, miR-421 was significantly up-regulated in those tumors with lymph node metastasis (P<0.05), while those tumors with no lymph node metastasis had normal miR-421 level as those in control group (P>0.05). These results suggested the correlation between miR-421 up-regulation and lymph node metastasis. Those patients with high miR-421 expression had significantly shorter survival time compared to normal miR-421 patients (median: 37.34 months vs. 54.23 months, P<0.01), suggesting the correlation between miR-421 expression and prognosis of gastric cancer. MiR-421 level is correlated with lymph node metastasis and prognosis of gastric carcinoma, and is worth for further investigations.

Entities:  

Keywords:  Gastric carcinoma; MicroRNA-421; correlation analysis; prognosis prediction

Mesh:

Substances:

Year:  2015        PMID: 26823855      PMCID: PMC4713641     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Combinatorial microRNA target predictions.

Authors:  Azra Krek; Dominic Grün; Matthew N Poy; Rachel Wolf; Lauren Rosenberg; Eric J Epstein; Philip MacMenamin; Isabelle da Piedade; Kristin C Gunsalus; Markus Stoffel; Nikolaus Rajewsky
Journal:  Nat Genet       Date:  2005-04-03       Impact factor: 38.330

3.  A guide through present computational approaches for the identification of mammalian microRNA targets.

Authors:  Praveen Sethupathy; Molly Megraw; Artemis G Hatzigeorgiou
Journal:  Nat Methods       Date:  2006-11       Impact factor: 28.547

4.  miR-429 modulates the expression of c-myc in human gastric carcinoma cells.

Authors:  Tiewei Sun; Chunmei Wang; Jun Xing; Dequan Wu
Journal:  Eur J Cancer       Date:  2011-06-16       Impact factor: 9.162

5.  MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.

Authors:  Clemens L Bockmeyer; Matthias Christgen; Mirco Müller; Sebastian Fischer; Philipp Ahrens; Florian Länger; Hans Kreipe; Ulrich Lehmann
Journal:  Breast Cancer Res Treat       Date:  2011-03-17       Impact factor: 4.872

6.  MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.

Authors:  Jianhong Wu; Guangxin Li; Yongliang Yao; Zeyou Wang; Wangwei Sun; Jianjun Wang
Journal:  Biomarkers       Date:  2014-12-16       Impact factor: 2.658

7.  miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4.

Authors:  Liang Chen; Yanping Tang; Jian Wang; Zhongjie Yan; Ruxiang Xu
Journal:  Biochem Biophys Res Commun       Date:  2013-05-23       Impact factor: 3.575

8.  Gastric juice microRNA-421 is a new biomarker for screening gastric cancer.

Authors:  Xinjun Zhang; Long Cui; Guoliang Ye; Tuo Zheng; Haojun Song; Tian Xia; Xiuchong Yu; Bingxiu Xiao; Yanping Le; Junming Guo
Journal:  Tumour Biol       Date:  2012-08-29

9.  Down-regulation of miR-141 in gastric cancer and its involvement in cell growth.

Authors:  Ying Du; Yanjun Xu; Ling Ding; Haomi Yao; Hong Yu; Tianhua Zhou; Jianmin Si
Journal:  J Gastroenterol       Date:  2009-04-11       Impact factor: 7.527

10.  Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.

Authors:  Tim Eiseler; Heike Döppler; Irene K Yan; Steve Goodison; Peter Storz
Journal:  Breast Cancer Res       Date:  2009-02-25       Impact factor: 6.466

View more
  13 in total

Review 1.  Noncoding RNAs in gastric cancer: Research progress and prospects.

Authors:  Meng Zhang; Xiang Du
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

2.  MicroRNA-421 promotes the proliferation and metastasis of gastric cancer cells by targeting claudin-11.

Authors:  Peng Yang; Mei Zhang; Xiting Liu; Huayun Pu
Journal:  Exp Ther Med       Date:  2017-07-17       Impact factor: 2.447

3.  Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.

Authors:  Xiwen Liao; Xiangkun Wang; Ketuan Huang; Chengkun Yang; Tingdong Yu; Chuangye Han; Guangzhi Zhu; Hao Su; Rui Huang; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-08-10       Impact factor: 3.989

4.  Upregulation of the APE1 and H2AX genes and miRNAs involved in DNA damage response and repair in gastric cancer.

Authors:  Fernanda S Manoel-Caetano; Ana Flávia T Rossi; Gabriela Calvet de Morais; Fábio Eduardo Severino; Ana Elizabete Silva
Journal:  Genes Dis       Date:  2019-04-05

5.  Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer.

Authors:  Jianlin Chen; Lihua Wu; Yifan Sun; Qi Yin; Xianhua Chen; Siqun Liang; Qingyan Meng; Haihua Long; Fangying Li; Changjun Luo; Xiaorong Xiao
Journal:  PeerJ       Date:  2019-06-17       Impact factor: 2.984

6.  Propofol Suppresses Proliferation, Migration, Invasion And Promotes Apoptosis By Upregulating microRNA-140-5p In Gastric Cancer Cells.

Authors:  Fengbo Zhu; Qiuxia Li; Ying Yang; Liangui Wang; Jing Wang
Journal:  Onco Targets Ther       Date:  2019-11-25       Impact factor: 4.147

7.  Prognostic value of microRNAs in gastric cancer: a meta-analysis.

Authors:  Yue Zhang; Dong-Hui Guan; Rong-Xiu Bi; Jin Xie; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-06-21

8.  Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer.

Authors:  Yunxia Li; Xiaomei Cui; Yongdeng Li; Tingting Zhang; Shuyun Li
Journal:  Cancer Manag Res       Date:  2018-08-13       Impact factor: 3.989

9.  miRNAs as potential biomarkers for the progression of gastric cancer inhibit CREBZF and regulate migration of gastric adenocarcinoma cells.

Authors:  Yu Jin Kim; Seongtae Jeong; Woon Yong Jung; Jung-Won Choi; Ki-Chul Hwang; Sang Woo Kim; Yong Chan Lee
Journal:  Int J Med Sci       Date:  2020-02-24       Impact factor: 3.738

10.  Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin.

Authors:  Li-Qun Ren; Qi Li; Yang Zhang
Journal:  Biomed Res Int       Date:  2020-02-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.